Approval · Notice of Compliance 11302 · 2010
AA-AMITRIPTYLINE: Notice of Compliance 11302
Issued April 27, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11302
- Date
- April 27, 2010
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AA-AMITRIPTYLINE | 02348942 | — |
Medicinal ingredients
- AMITRIPTYLINE HCL 75 MG per TAB